Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation.

Atretkhany KS, Nosenko MA, Gogoleva VS, Zvartsev RV, Qin Z, Nedospasov SA, Drutskaya MS.

Front Immunol. 2016 Apr 19;7:147. doi: 10.3389/fimmu.2016.00147. eCollection 2016.

2.

Inflammation, fracture and bone repair.

Loi F, Córdova LA, Pajarinen J, Lin TH, Yao Z, Goodman SB.

Bone. 2016 May;86:119-30. doi: 10.1016/j.bone.2016.02.020. Epub 2016 Mar 2. Review.

PMID:
26946132
3.

Elevated Lifetime Lead Exposure Impedes Osteoclast Activity and Produces an Increase in Bone Mass in Adolescent Mice.

Beier EE, Holz JD, Sheu TJ, Puzas JE.

Toxicol Sci. 2016 Feb;149(2):277-88. doi: 10.1093/toxsci/kfv234. Epub 2015 Oct 30.

PMID:
26518054
4.

Interaction of Materials and Biology in Total Joint Replacement - Successes, Challenges and Future Directions.

Pajarinen J, Lin TH, Sato T, Yao Z, Goodman S.

J Mater Chem B Mater Biol Med. 2014 Nov 7;2(41):7094-7108.

5.

Mitigative effect of erythromycin on PMMA challenged preosteoblastic MC3T3-E1 cells.

Shen Y, Wang W, Li X, Markel DC, Ren W.

ScientificWorldJournal. 2014;2014:107196. doi: 10.1155/2014/107196. Epub 2014 Jun 3.

6.

Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target.

Lin TH, Tamaki Y, Pajarinen J, Waters HA, Woo DK, Yao Z, Goodman SB.

Acta Biomater. 2014 Jan;10(1):1-10. doi: 10.1016/j.actbio.2013.09.034. Epub 2013 Oct 1. Review.

7.

A TNF variant that associates with susceptibility to musculoskeletal disease modulates thyroid hormone receptor binding to control promoter activation.

Kiss-Toth E, Harlock E, Lath D, Quertermous T, Wilkinson JM.

PLoS One. 2013 Sep 19;8(9):e76034. doi: 10.1371/journal.pone.0076034. eCollection 2013.

8.
9.

Role of direct estrogen receptor signaling in wear particle-induced osteolysis.

Nich C, Rao AJ, Valladares RD, Li C, Christman JE, Antonios JK, Yao Z, Zwingenberger S, Petite H, Hamadouche M, Goodman SB.

Biomaterials. 2013 Jan;34(3):641-50. doi: 10.1016/j.biomaterials.2012.10.030. Epub 2012 Oct 29.

10.

Inhibiting wear particles-induced osteolysis with naringin.

Yu X, Zhao X, Wu T, Zhou Z, Gao Y, Wang X, Zhang CQ.

Int Orthop. 2013 Jan;37(1):137-43. doi: 10.1007/s00264-012-1668-5. Epub 2012 Oct 31.

11.

Periprosthetic osteolysis: genetics, mechanisms and potential therapeutic interventions.

Noordin S, Masri B.

Can J Surg. 2012 Dec;55(6):408-17. doi: 10.1503/cjs.003711. Review.

12.

Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application.

Song W, Yu X, Wang S, Blasier R, Markel DC, Mao G, Shi T, Ren W.

Int J Nanomedicine. 2011;6:3173-86. doi: 10.2147/IJN.S23530. Epub 2011 Dec 8.

13.

Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model.

Ren W, Zhang R, Wu B, Wooley PH, Hawkins M, Markel DC.

J Inflamm Res. 2011;4:29-38. doi: 10.2147/JIR.S16232. Epub 2011 Mar 2.

14.

Actin and ERK1/2-CEBPβ signaling mediates phagocytosis-induced innate immune response of osteoprogenitor cells.

Lee HG, Minematsu H, Kim KO, Celil Aydemir AB, Shin MJ, Nizami SA, Chung KJ, Hsu AC, Jacobs CR, Lee FY.

Biomaterials. 2011 Dec;32(35):9197-206. doi: 10.1016/j.biomaterials.2011.08.059. Epub 2011 Sep 6.

15.

Oestrogen deficiency modulates particle-induced osteolysis.

Nich C, Langlois J, Marchadier A, Vidal C, Cohen-Solal M, Petite H, Hamadouche M.

Arthritis Res Ther. 2011 Jun 22;13(3):R100. doi: 10.1186/ar3381.

16.

Emerging ideas: can erythromycin reduce the risk of aseptic loosening?

Ren W, Markel DC.

Clin Orthop Relat Res. 2011 Aug;469(8):2399-403. doi: 10.1007/s11999-011-1918-7. Epub 2011 May 17.

17.

New animal models of wear-particle osteolysis.

Langlois J, Hamadouche M.

Int Orthop. 2011 Feb;35(2):245-51. doi: 10.1007/s00264-010-1143-0. Epub 2010 Nov 12. Review.

18.

In vivo imaging of particle-induced inflammation and osteolysis in the calvariae of NFκB/luciferase transgenic mice.

Takahashi K, Onodera S, Tohyama H, Kwon HJ, Honma K, Yasuda K.

J Biomed Biotechnol. 2011;2011. pii: 727063. doi: 10.1155/2011/727063. Epub 2010 Sep 21.

19.

Co-Cr-Mo alloy particles induce tumor necrosis factor alpha production in MLO-Y4 osteocytes: a role for osteocytes in particle-induced inflammation.

Kanaji A, Caicedo MS, Virdi AS, Sumner DR, Hallab NJ, Sena K.

Bone. 2009 Sep;45(3):528-33. doi: 10.1016/j.bone.2009.05.020. Epub 2009 Jun 2.

20.

The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.

Li G, Wu P, Xu Y, Yu Y, Sun L, Zhu L, Ye D.

BMC Musculoskelet Disord. 2009 Jun 2;10:57. doi: 10.1186/1471-2474-10-57.

Items per page

Supplemental Content

Write to the Help Desk